市場調查報告書
商品編碼
926704

COPD藥物輸送設備市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測

COPD Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版日期: | 出版商: Transparency Market Research | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球COPD藥物輸送設備市場相關調查,彙整市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場分析與預測

第5章 市場預測

  • 主要國家的疾病罹患率
  • 主要市場活動
  • 法律規章方案

第6章 市場值與預測:各產品

  • 簡介和定義
  • 主要調查結果/發展
  • 市場值預測
    • 吸入器
    • 噴霧器
  • 市場魅力度

第7章 市場值與預測:各類型

  • 簡介和定義
  • 主要調查結果/發展
  • 市場值預測
    • 手動設備
    • 數位設備
  • 市場魅力度

第8章 市場值與預測:不同流通管道

  • 簡介和定義
  • 主要調查結果/發展
  • 市場值預測
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 市場魅力度

第9章 市場值與預測:各地區

  • 主要調查結果
  • 市場值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力度

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭環境

  • 競爭矩陣
  • 市場佔有率分析
  • 企業簡介
目錄
Product Code: TMRGL74897

Title:
COPD Drug Delivery Devices Market (Product: Inhalers and Nebulizers; Type: Manual Devices and Digital Devices; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

COPD Drug Delivery Devices Market - Scope of the Report

TMR's report on the global COPD drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global COPD drug delivery devices market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global COPD drug delivery devices market from 2019 to 2027.

The report has been prepared after an extensive research. Primary research involves bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global COPD drug delivery devices market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global COPD drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global COPD drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global COPD drug delivery devices market.

The report delves into the competitive landscape of the global COPD drug delivery devices market. Key players operating in the global COPD drug delivery devices market have been identified and each one of them has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global COPD drug delivery devices market that have been profiled in this report.

Key Questions Answered in COPD Drug Delivery Devices Market Report

What is the sales/revenue generated by COPD drug delivery devices market across all regions during the forecast period?

What are the opportunities in the global COPD drug delivery devices market?

What are the major drivers, restraints, opportunities, and threats in the global market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which product segment is expected to generate the highest revenue globally in 2027? Which segment is projected expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

COPD Drug Delivery Devices Market - Research Objectives and Research Approach

The comprehensive report on the global COPD drug delivery devices market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global COPD drug delivery devices market in terms of product, type, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global COPD drug delivery devices market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global COPD Drug Delivery Devices Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global COPD Drug Delivery Devices Market Analysis and Forecast, 2017-2027

5. Key Insights

  • 5.1. Disease Prevalence in Key Countries
  • 5.2. Key Market Events
  • 5.3. Regulatory Scenario

6. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 6.3.1. Inhaler
      • 6.3.1.1. Metered Dose Inhaler
      • 6.3.1.2. Dry Powder Inhaler
      • 6.3.1.3. Soft Mist Inhaler
    • 6.3.2. Nebulizer
      • 6.3.2.1. Jet Nebulizer
      • 6.3.2.2. Mesh Nebulizer
      • 6.3.2.3. Ultrasonic Nebulizer
  • 6.4. Global COPD Drug Delivery Devices Market Attractiveness, by Product

7. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global COPD Drug Delivery Devices Market Value (US$) Forecast, by Type, 2017-2027
    • 7.3.1. Manual Device
    • 7.3.2. Digital Device
  • 7.4. Global COPD Drug Delivery Devices Market Attractiveness, by Type

8. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Global COPD Drug Delivery Devices Market Attractiveness, by Distribution Channel

9. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global COPD Drug Delivery Devices Market Attractiveness, by Region

10. North America COPD Drug Delivery Devices Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 10.2.1. Inhaler
      • 10.2.1.1. Metered Dose Inhaler
      • 10.2.1.2. Dry Powder Inhaler
      • 10.2.1.3. Soft Mist Inhaler
    • 10.2.2. Nebulizer
      • 10.2.2.1. Jet Nebulizer
      • 10.2.2.2. Mesh Nebulizer
      • 10.2.2.3. Ultrasonic Nebulizer
  • 10.3. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 10.3.1. Manual Device
    • 10.3.2. Digital Device
  • 10.4. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America COPD Drug Delivery Devices Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe COPD Drug Delivery Devices Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 11.2.1. Inhaler
      • 11.2.1.1. Metered Dose Inhaler
      • 11.2.1.2. Dry Powder Inhaler
      • 11.2.1.3. Soft Mist Inhaler
    • 11.2.2. Nebulizer
      • 11.2.2.1. Jet Nebulizer
      • 11.2.2.2. Mesh Nebulizer
      • 11.2.2.3. Ultrasonic Nebulizer
  • 11.3. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 11.3.1. Manual Device
    • 11.3.2. Digital Device
  • 11.4. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe COPD Drug Delivery Devices Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific COPD Drug Delivery Devices Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 12.2.1. Inhaler
      • 12.2.1.1. Metered Dose Inhaler
      • 12.2.1.2. Dry Powder Inhaler
      • 12.2.1.3. Soft Mist Inhaler
    • 12.2.2. Nebulizer
      • 12.2.2.1. Jet Nebulizer
      • 12.2.2.2. Mesh Nebulizer
      • 12.2.2.3. Ultrasonic Nebulizer
  • 12.3. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 12.3.1. Manual Device
    • 12.3.2. Digital Device
  • 12.4. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America COPD Drug Delivery Devices Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 13.2.1. Inhaler
      • 13.2.1.1. Metered Dose Inhaler
      • 13.2.1.2. Dry Powder Inhaler
      • 13.2.1.3. Soft Mist Inhaler
    • 13.2.2. Nebulizer
      • 13.2.2.1. Jet Nebulizer
      • 13.2.2.2. Mesh Nebulizer
      • 13.2.2.3. Ultrasonic Nebulizer
  • 13.3. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 13.3.1. Manual Device
    • 13.3.2. Digital Device
  • 13.4. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America COPD Drug Delivery Devices Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa COPD Drug Delivery Devices Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 14.2.1. Inhaler
      • 14.2.1.1. Metered Dose Inhaler
      • 14.2.1.2. Dry Powder Inhaler
      • 14.2.1.3. Soft Mist Inhaler
    • 14.2.2. Nebulizer
      • 14.2.2.1. Jet Nebulizer
      • 14.2.2.2. Mesh Nebulizer
      • 14.2.2.3. Ultrasonic Nebulizer
  • 14.3. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 14.3.1. Manual Device
    • 14.3.2. Digital Device
  • 14.4. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Israel
    • 14.5.4. Rest of Middle East & Africa
  • 14.6. Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Type
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Competition Matrix
  • 15.2. Market Share Analysis, by Company (2018)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Company Financials
      • 15.3.1.3. Growth Strategies
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Boehringer Ingelheim GmbH
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Company Financials
      • 15.3.2.3. Growth Strategies
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. GlaxoSmithKline plc
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Company Financials
      • 15.3.3.3. Growth Strategies
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Novartis AG
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Company Financials
      • 15.3.4.3. Growth Strategies
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. Teva Pharmaceutical Industries
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Company Financials
      • 15.3.5.3. Growth Strategies
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Merck & Co., Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Company Financials
      • 15.3.6.3. Growth Strategies
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Cipla Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Company Financials
      • 15.3.7.3. Growth Strategies
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Sunovion Pharmaceuticals, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Company Financials
      • 15.3.8.3. Growth Strategies
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Koninklijke Philips N.V.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Company Financials
      • 15.3.9.3. Growth Strategies
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. PARI GmbH
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Growth Strategies
      • 15.3.10.3. SWOT Analysis
    • 15.3.11. Omron Corporation
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Company Financials
      • 15.3.11.3. Growth Strategies
      • 15.3.11.4. SWOT Analysis

List of Tables

  • Table 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 02: Global COPD Drug Delivery Devices Market, by Inhaler, 2017-2027
  • Table 03: Global COPD Drug Delivery Devices Market, by Nebulizer, 2017-2027
  • Table 04: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 05: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 07: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 08: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017-2027
  • Table 09: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017-2027
  • Table 10: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 11: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 12: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 13: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 14: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017-2027
  • Table 15: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017-2027
  • Table 16: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 17: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 18: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 19: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 20: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017-2027
  • Table 21: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017-2027
  • Table 22: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 23: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 24: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 25: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 26: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017-2027
  • Table 27: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017-2027
  • Table 28: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 29: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 30: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 31: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 32: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017-2027
  • Table 33: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017-2027
  • Table 34: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 35: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 36: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figures

  • Figure 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 02: Global COPD Drug Delivery Devices Market Value Share, by Product, 2018
  • Figure 03: Global COPD Drug Delivery Devices Market Value Share, by Type, 2018
  • Figure 04: Global COPD Drug Delivery Devices Market Value Share, by Distribution Channel, 2018
  • Figure 05: Global COPD Drug Delivery Devices Market Value Share, by Region, 2018
  • Figure 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 07: Global COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 08: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Inhaler, 2017-2027
  • Figure 09: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Nebulizer, 2017-2027
  • Figure 10: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 11: Global COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 12: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Manual Device, 2017-2027
  • Figure 13: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digital Device, 2017-2027
  • Figure 14: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 15: Global COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 16: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017-2027
  • Figure 17: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017-2027
  • Figure 18: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017-2027
  • Figure 19: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 20: Global COPD Drug Delivery Devices Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 21: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 22: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 23: North America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 24: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 25: North America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 26: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 27: North America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 28: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 29: North America COPD Drug Delivery Devices Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 30: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 31: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 32: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 33: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 34: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 35: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 36: Figure 36: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 37: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 38: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 39: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 40: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 41: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 42: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 43: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 44: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 45: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 46: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 47: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 48: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 49: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 50: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 51: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 52: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 53: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 54: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 55: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 56: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 57: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 58: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 59: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 60: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 61: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 62: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 63: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 64: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 65: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub region, 2018 and 2027
  • Figure 66: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 67: Global COPD Drug Delivery Devices Market Share, by Company, 2018
  • Figure 68: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 69: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 70: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018
  • Figure 71: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 72: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 73: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018
  • Figure 74: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 75: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 76: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 77: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018
  • Figure 78: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 79: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 80: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 81: Novartis AG Breakdown of Net Sales (%), by Country, 2018
  • Figure 82: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 83: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 84: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 85: Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales (%), by Segment, 2018
  • Figure 86: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 87: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 88: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018
  • Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 90: Cipla Inc., Revenue (US$ Mn), 2015-2018
  • Figure 91: Cipla Inc., Breakdown of Net Sales (%), Therapy-wise, 2018
  • Figure 92: Cipla Inc., Breakdown of Net Sales (%), by Region, 2018
  • Figure 93: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 94: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 95: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017
  • Figure 96: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Net Sales (%), by Product Segment, 2017
  • Figure 97: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 98: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 99: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region, 2018
  • Figure 100: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 101: Omron Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 102: Omron Corporation (Healthcare Business) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 103: Omron Corporation (Healthcare Business) Breakdown of Net Sales (%), by Region, 2018
  • Figure 104: Omron Corporation Breakdown of Net Sales (%), by Business Segment, 2018